Legal Representation
Attorney
Rosemary S. Tarlton
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 22, 2005 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jun 22, 2005 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Dec 29, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Dec 13, 2004 | UNPR | I | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | Loading... |
| Dec 13, 2004 | I | PAPER RECEIVED | Loading... | |
| Oct 24, 2004 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 24, 2004 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 7, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Sep 20, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 20, 2004 | I | PAPER RECEIVED | Loading... | |
| Jul 30, 2004 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 30, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 13, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biological chemical diagnostic test kits for clinical or medical laboratory use, namely, for use in analysis of gene expression, genetics, single nucleotide polymorphism, haphotypes, proteins, and biological samples, for use in detecting diseases, for use in determining the progression of diseases, and for use in determining drug responses; diagnostic medical reagents, chemicals and solid matrix materials for biological, clinical or medical laboratory use for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, developmental disorders and cancer
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"DIAGNOSTICS"